Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 8 to 10 amino acid residues in defined sequence
Reexamination Certificate
2011-06-21
2011-06-21
Landsman, Robert (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
8 to 10 amino acid residues in defined sequence
C514S010200, C514S019400, C514S021600
Reexamination Certificate
active
07964701
ABSTRACT:
The invention relates to compounds that include peptides that inhibit estrogen receptor dependent cell proliferation. The compounds of the invention are useful for treating cell proliferative disorders or physiological conditions characterized by undesirable or unwanted estrogen induced cell proliferation, including breast cancer.
REFERENCES:
patent: 5674842 (1997-10-01), Mizejewski
patent: 5707963 (1998-01-01), Mizejewski
patent: 6121236 (2000-09-01), Ben-Sasson
patent: 6306832 (2001-10-01), Pietras
patent: 6348567 (2002-02-01), Krystal et al.
patent: 6818741 (2004-11-01), Andersen et al.
patent: 7122522 (2006-10-01), Andersen et al.
patent: 7132400 (2006-11-01), Andersen et al.
patent: 2005/0271587 (2005-12-01), Andersen et al.
Joseph et al., 2009, Journal of Peptide Science, vol. 15, pp. 319-325.
Jacobson et al , “Inhibition of Estrogen-dependent Breast Cancer Growth by a Reaction Product of α-Fetoprotein and Estradiol”,Cancer Researchvol. 50, 415-420, Jan. 15, 1990.
Bennett et al., “α-Fetoprotein Derived from a Human Hepatoma Prevents Growth of Estrogen-dependent Human Breast Cancer Xenografts”,Clinical Cancer Research, vol. 4, 287-2884, Nov. 1998.
Mesfin et al., “Development of a synthetic cyclized peptide derived from α-fetoprotein that prevents the growth of human breast cancer”,J. Peptide Res., 2001, vol. 58, 246-256.
Defreest et al., “Synthetic peptide derived from α-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization”,J. Peptide Res., 2004, vol. 63, 409-419.
Bennett et al., “A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen”,PNAS, 2002; vol. 99, 2211-2215.
Eisele et al., “Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs”,J. Peptide Res., 2001, vol. 57, 29-38.
Eisele et al., “Studies on analogs of a peptide derived from alpha-fetoprotein having antigrowth properties”,J. Peptide Res., 2001, vol. 57, 539-546.
Aggarwal et al., “Synthesis and Screening of a Random Dimeric Peptide Library Using the One-Bead-One Dimer Combinatorial Approach”,Bioconjugate Chem., 2006, vol. 17, 335-340.
Aggarwal et al., “A Dimeric Peptide that Binds Selectively to Prostate-Specific Membrane Antigen and Inhibits its Enzymatic Activity”,Cancer Res 2006, vol. 66: (18): 9171-9177 Sep. 15, 2006.
O'Leary et al., “Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor”,The Journal of Biological Chemistry, vol. 278, No. 28, Jul. 11, 2003, 25738-25744.
Kirschner et al., “Computational Design and Experimental Discovery of an Anti-estrogenic Peptide Derived from Alpha-Fetoprotein”,J. Am. Chem. Soc., 2007, vol. 129(19), 6263-6268.
Parikh et al., “Prevention ofN-Methyl-N-Nitrosourea-Induced Breast Cancer by α-Fetoprotein (AFP)—Derived Peptide, a Peptide Derived from the Active Site of AFP”,Clin Cancer Res, 2005; 11(23) Dec. 1, 2005; 8512-8520.
Mizejewski et al., “α-Fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics”,Mol Cancer Ther., 2003;2: 1243-1255.
Mesfin et al., “Alpha-fetoprotein-derived antiestrotrophic octapeptide”,Biochimica et Biophysica Acta1501 (2000) 33-43.
Joseph et al., Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein,Journal of Peptide. Science, 2008, 14; 1-7.
Andersen Thomas T.
Bennett James A.
Jacobson Herbert
Albany Medical College
Dang Ian
Dias Kathy Smith
Heslin Rothenberg Farley & & Mesiti P.C.
Landsman Robert
LandOfFree
Alpha-fetoprotein peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-fetoprotein peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-fetoprotein peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2717641